MedTrace Logo

Secondary Prevention of Osteoporosis

NCT00421343 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2020-02-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to develop and implement an evidence based protocol for the secondary prevention of osteoporotic fractures and falls, and to determine how compliance with this intervention improves muscle strength and functional status following a fracture.

Conditions

Interventions

DRUG

alendronate with cholecalciferol

alendronate 70mg /cholecalciferol 2800IU orally once weekly

DRUG

calcium carbonate with cholecalciferol

calcium carbonate 500mg /cholecalciferol 200IU orally twice daily

BEHAVIORAL

Falls prevention measures

personalized exercises, home safety evaluation, referral to an eye doctor if needed, review of medications

Sponsors & Collaborators

Principal Investigators

  • Sarah D Berry, MD, MPH · Harvard University, Hebrew Rehabilitation Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00421343 on ClinicalTrials.gov